**Question:** Diagnostic test for Disseminated Intravascular Coagulation is: September 2011

A. Prothrombin Time (PT)
B. Partial Thromboplastin Time (PTT)
C. Activated Partial Thromboplastin Time (aPTT)
D. D-Dimer

**Correct Answer:** D. D-Dimer

**Core Concept:**
Disseminated Intravascular Coagulation (DIC) is a hypercoagulable state characterized by widespread intravascular clot formation, fibrinolysis, and consumption of coagulation factors leading to organ dysfunction and failure. It is commonly triggered by severe trauma, infections, and malignancies. The coagulation cascade is a complex series of reactions involving multiple factors, such as thrombin, fibrinogen, and clotting factors.

**Why the Correct Answer is Right:** D-Dimer is a plasma protein fragment generated during the breakdown of fibrin clots. Elevated D-Dimer levels are a sensitive but not specific marker for the presence of active clot formation or clot resolution. In the context of DIC, an elevated D-Dimer indicates ongoing clot formation and is used as a screening tool to diagnose DIC.

**Why Each Wrong Option is Incorrect:**

A. Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) are clotting time tests that assess the extrinsic and intrinsic pathways of clotting, respectively. These tests are not specific for DIC and can be elevated in other conditions with coagulopathy, making them unsuitable for diagnosing DIC.

B. Activated Partial Thromboplastin Time (aPTT) is a clotting time test that assesses the intrinsic pathway of clotting. Similar to PT and PTT, aPTT is not specific to DIC and elevated levels can be seen in other coagulopathy conditions.

C. Unlike D-Dimer, PT, PTT, and aPTT tests assess the overall clotting system and do not specifically indicate ongoing clot formation or resolution.

**Clinical Pearl:** DIC is a critical condition that requires prompt recognition and intervention to prevent complications and organ failure. D-Dimer testing, when combined with clinical symptoms and signs, can aid in the diagnosis of DIC. Early recognition and management can improve patient outcomes.